Access Ultrasensitive Insulin only used on the DxI 9000 Access Immunoassay Analyzer, Catalog Numb...

FDA Device Recall #Z-0981-2024 — Class II — November 21, 2023

Recall Summary

Recall Number Z-0981-2024
Classification Class II — Moderate risk
Date Initiated November 21, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Beckman Coulter, Inc.
Location Chaska, MN
Product Type Devices
Quantity 19,125 reagent packs

Product Description

Access Ultrasensitive Insulin only used on the DxI 9000 Access Immunoassay Analyzer, Catalog Number 33410

Reason for Recall

There is an issue with the Access Ultrasensitive Insulin assay protocol file (APF) for use with the DxI 9000 Access Immunoassay Analyzer (APF 182 test definition version 6.7 and below). The Access Ultrasensitive Insulin APF applies an incorrect conversion factor when converting from system default units of ¿IU/mL to the International System of Units (SI units) of pmol/L.

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Croatia, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom.

Lot / Code Information

UDI/DI 15099590230623, Lot Numbers: 125533, 125589, 233656, 233919, 234055, 234339, 234388

Other Recalls from Beckman Coulter, Inc.

Recall # Classification Product Date
Z-1235-2026 Class II CellMek SPS Sample Preparation System, REF: C44... Dec 23, 2025
Z-1026-2026 Class II Beckman Coulter UniCel Dxl 800, Part numbers: ... Nov 26, 2025
Z-1025-2026 Class II Beckman Coulter UniCel Dxl 600, Part numbers: ... Nov 26, 2025
Z-1221-2026 Class II COULTER DxH Diluent, REF 628017 COULTER DxH EC... Nov 10, 2025
Z-0889-2026 Class II Access 2 Reaction Vessels, individual, disposab... Nov 7, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.